BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 284 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2024. The put-call ratio across all filers is 1.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,827 | +11.7% | 25,883 | 0.0% | 0.01% | 0.0% |
| Q1 2024 | $2,531 | +8.4% | 25,883 | +2.9% | 0.01% | 0.0% |
| Q4 2023 | $2,334 | +81.9% | 25,150 | 0.0% | 0.01% | +66.7% |
| Q3 2023 | $1,283 | -22.7% | 25,150 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,660 | +49.7% | 25,150 | 0.0% | 0.00% | +33.3% |
| Q1 2023 | $1,109 | +4.0% | 25,150 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,066 | -99.9% | 25,150 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $1,624,000 | +26.6% | 25,150 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $1,283,000 | -21.6% | 25,150 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $1,636,000 | -36.7% | 25,150 | +4.6% | 0.00% | -33.3% |
| Q4 2021 | $2,584,000 | +8.1% | 24,050 | +2.6% | 0.01% | -14.3% |
| Q3 2021 | $2,391,000 | +19.1% | 23,450 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $2,008,000 | -6.6% | 23,450 | 0.0% | 0.01% | -14.3% |
| Q1 2021 | $2,149,000 | -16.0% | 23,450 | +5.4% | 0.01% | -30.0% |
| Q4 2020 | $2,558,000 | -7.1% | 22,250 | -27.9% | 0.01% | -16.7% |
| Q3 2020 | $2,754,000 | +1430.0% | 30,850 | +1273.6% | 0.01% | +1100.0% |
| Q4 2019 | $180,000 | -94.3% | 2,246 | -93.5% | 0.00% | -93.8% |
| Q2 2019 | $3,184,000 | +162.7% | 34,346 | +111.0% | 0.02% | +128.6% |
| Q1 2019 | $1,212,000 | +72.6% | 16,280 | +17.3% | 0.01% | +40.0% |
| Q4 2018 | $702,000 | -42.1% | 13,875 | -14.8% | 0.01% | -28.6% |
| Q3 2018 | $1,212,000 | +19.2% | 16,280 | -2.4% | 0.01% | 0.0% |
| Q2 2018 | $1,017,000 | -25.5% | 16,680 | +6.2% | 0.01% | -22.2% |
| Q1 2018 | $1,365,000 | +88.0% | 15,700 | -1.9% | 0.01% | +50.0% |
| Q4 2017 | $726,000 | 0.0% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q3 2017 | $726,000 | -10.7% | 16,000 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $813,000 | +164.8% | 16,000 | -0.6% | 0.01% | +100.0% |
| Q2 2016 | $307,000 | +40.8% | 16,100 | +27.8% | 0.00% | 0.0% |
| Q1 2016 | $218,000 | – | 12,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 581,768 | $25,487,256 | 9.57% |
| Casdin Capital, LLC | 1,477,800 | $64,742,418 | 5.02% |
| Nextech Invest Ltd. | 188,228 | $8,246,269 | 3.28% |
| DAFNA Capital Management LLC | 261,235 | $11,444,705 | 3.22% |
| Rock Springs Capital Management LP | 1,891,510 | $82,867,053 | 1.99% |
| HealthCor Management, L.P. | 30,000 | $1,314,300 | 1.20% |
| EFG Asset Management (North America) Corp. | 110,853 | $4,766,679 | 1.07% |
| Novo Holdings A/S | 370,000 | $16,209,700 | 1.01% |
| SECTORAL ASSET MANAGEMENT INC | 115,900 | $5,077,579 | 0.98% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 305,709 | $13,393,111 | 0.83% |